Basic Information
| LncRNA/CircRNA Name | lncRNA00544 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | Microarray, qPCR |
| Sample | luminal BC tissues, breast cancer cell lines (MCF-7, ZR751, T47D, BCAP37, SKBR3, MDA-MB-453, MDA-MB-436, MDA-MB-231, MDA-MB-231HM) |
| Expression Pattern | up-regulated |
| Function Description | Here, we aim to identify the lncRNAs which are involved in the particular type luminal BC progression. By Gene Chips analysis, we found a novel lncRNA00544, which was highly expressed in the metastatic axillary nodes compared with corresponding luminal BC tissues (fold change=2.26, P=0.043).Many differentially expressed lncRNAs including circulating lncRNA and lncRNA signatures |
| Pubmed ID | 28959047 |
| Year | 2017 |
| Title | Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+HER2 subtype breast cancer |
External Links
| Links for lncRNA00544 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |